June 28 (Reuters) - Boston Scientific Corp. and CryoCor Inc. said they entered a deal to co-develop therapies for atrial fibrillation -- abnormal beating of the heart's upper chambers. CryoCor's ...
WASHINGTON, June 27 (Reuters) - A U.S. advisory panel backed an experimental CryoCor Inc. device to treat a type of abnormal heart rhythm, a Food and Drug Administration spokeswoman said on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback